InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,994.24
(
0.17%
)
US TECH 100
20,514.00
(
-0.01%
)
Dow Jones
44,011.85
(
0.23%
)
Brent Oil
71.86
(
0.34%
)
Bitcoin
90,873.98
(
3.35%
)
Post# of 52740
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jb528

Send PM Follow Ignore
Followers 1
Posts 282
Boards Moderated 0
Alias Born 02/27/2014

Jb528

Re: None

Wednesday, 03/14/2018 10:09:51 AM

Wednesday, March 14, 2018 10:09:51 AM

Post# of 52740
RCHA - .0005 news Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma

https://globenewswire.com/news-release/2018/03/14/1422455/0/en/Rich-Pharmaceuticals-Study-Drug-RP-323-TPA-is-a-Potential-Therapeutic-Agent-for-the-Treatment-of-Hodgkin-s-Lymphoma.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up